ENLV — Stock Film
STOCK FILMSCENE 1/11ENLV · $1.44
Stock Expert AI presents
ENLV
Enlivex Therapeutics Ltd
~4 min film100% real numbers0 jargon
WHAT DOES THIS COMPANY DO?
Enlivex Therapeutics Ltd. A quick introduction.

On the stock market since 2014, it operates in the world of health and science. It has 34 employees. Now — the numbers.

on the stock market since 2014
34 employees
$26.6M market value
Revenue last year:
$0
The net profit left over:
$0
Out of every $100 in sales, less than $1 stays as net profit.

This is an established company with proven profits.

THE SALES TREND
The sales picture, year by year.

Red columns mark years that ended in a loss.

$0
2021
$0
2022
$0
2023
$0
2024
$0
2025
Cash on hand:
$0
Total debt:
$0
The cash outweighs the debt.

If every debt were paid off today, $5.2M would still be left in the vault — a solid cushion for hard times.

Every quarter, analysts set a profit bar.
How many of the last 8 did the company clear?
5 / 8
EXPECTATIONS MET OR BEATEN
5
Aug 2024
Nov 2024
Mar 2025
May 2025
Aug 2025
Nov 2025
Mar 2026
Mar 2026
5 TIMES IN THE LAST 8 QUARTERS
A mixed scorecard.
THE COUNCIL REVIEW
9

angles, checked one by one.

The 2 that stand out are on screen; the rest came back neutral.

The council scores out of 10; report-card grades are out of 100.

WEAK SPOTS
The stock has lost its spark0/10
Thin profit on each sale3/10
WORTH WATCHING

Profit per Sale: The profit kept from each sale is thin.

THE FIVE-YEAR JOURNEY
A long and steep decline.

An investor who bought at the very peak is down 99% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.

1
THE BRIGHT SIDE · 1/2
Strong cash, light debt

There is $5.9M in the vault; even if every debt were paid off, $5.2M would remain.

2
THE BRIGHT SIDE · 2/2
Analysts’ target sits above today’s price

The average analyst price target is $15.00942% above today’s price.

1
THE RISKS · 1/2
The stock has lost its spark

Since the drop from its peak, buyer appetite hasn’t come back. Council score: 0/10.

2
THE RISKS · 2/2
Thin profit on each sale

As the slice kept from each sale thins out, so does the profit. Council score: 3/10.

FINALE · THE GRADE
D
0 / 100 · MoonshotScore

On our five-subject report card, ENLV sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”

The takeaway: ENLV is an established business that has proven its profits for years. The real debate isn’t the quality of the business — it’s whether the price paid for the stock is too high.

What would you like to do next?
Open the stock page →
This was a film — not investment advice.
Data: FMP & company filings
Aug 21, 2026 · stockexpertai.com · Stock Film